Weekly Versus Monthly Testosterone Administration on Fast and Slow Skeletal Muscle Fibers in Older Adult Males
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Context: In older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types is unknown.Objective: To determine the efficacy of WK vs MO T replacement on the size and functional capacity of individual fast and slow skeletal muscle fiber types.Design, Setting, and Patients: Subjects were randomized into a 5-month, double-blind, placebo-controlled trial.All subjects (ages, 61-71 y) were community-dwelling men who had T levels Ͻ 500 ng/dL.Intervention: Subjects were dosed weekly for 5 months, receiving continuous T (WK, n ϭ 5; 100 mg T enanthate, im injection), monthly cycled T (MO, n ϭ 7; alternating months of T and placebo), or placebo (n ϭ 7).Muscle biopsies of the vastus lateralis were obtained before and after treatment.Main Outcome Measures: Main outcomes for individual slow and fast fibers included fiber diameter, peak force (P 0 ), rate of tension development, maximal shortening velocity, peak power, and Ca 2ϩ sensitivity.Results: Both treatments increased fiber diameter and peak power, with WK treatment 5-fold more effective than MO in increasing type I fiber P 0 .WK effects on fiber diameter and force were 1.5-fold higher in slow fibers compared to fast fibers.In fast type II fibers, diameter and P 0 increased similarly between treatments.The increased power was entirely due to increased fiber size and force. Conclusions:In conclusion, T replacement effects were fiber-type dependent, restricted to increases in cell size, P 0 , and peak power, and dependent on the paradigm selected (WK vs MO).(J Clin Endocrinol Metab 100: E223-E231, 2015) T he loss of muscle mass and strength with age can greatly limit the ability of older adults to maintain normal daily activities and physical function (1-4).This problem is exacerbated in hypogonadal men with low T (5).T replacement therapy has been shown to protect against losses in muscle mass and strength by increasing muscle protein synthesis and decreasing protein degradation (5, 6).The gains observed with T treatment are both age-and dose-dependent, with greater effects typically seen in younger compared to older men (5, 7).Ferrando et al (6) found that chronic T administration increased lean body mass and strength in older men and, in the fasted state, stimulated reutilization of intracellular amino acids produced during protein breakdown.The observed decrease in protein breakdown in the T-treated group is important because an age-associated increase in skeletal
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.81 · Cited by 3,087
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544
Ferrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522
Self-citationSinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A. B., Lee, M. I., Storer, T. W., Casaburi, R., Shen, R., & Bhasin, S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00502.2001 · Cited by 464
Brodsky, I. G., Balagopal, P., & Nair, K. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855787 · Cited by 444
The Relationship of Strength to Function in the Older Adult
Fukagawa, N. K., Brown, M., Sinacore, D. R., & Host, H. H. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.55 · Cited by 321
Review Article: Exercise, Aging, and Muscle Protein Metabolism
Yarasheski, K. E. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.10.m918 · Cited by 173
Cited by
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease
Marty, E., Liu, Y., Samuel, A., Or, O., & Lane, J. (2017) · Bone · doi:10.1016/j.bone.2017.09.008 · Cited by 288
Horwath, O., Apró, W., Moberg, M., Godhe, M., Helge, T., Ekblom, M., Hirschberg, A. L., & Ekblom, B. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2019 · Cited by 70
Effect of 20-hydroxyecdysone on proteolytic regulation in skeletal muscle atrophy
HIRUNSAI, M., YIMLAMAI, T., & SUKSAMRARN, A. (2016) · In Vivo · doi:10.21873/invivo.11007 · Cited by 13
Denben, B., Sripinyowanich, S., Ruangthai, R., & Phoemsapthawee, J. (2023) · Sports · doi:10.3390/sports11090175 · Cited by 6
Metadata
- Authors
- Fitts, R. H., Peters, J. R., Dillon, E. L., Durham, W. J., Sheffield-Moore, M., & Urban, R. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-02
- Volume
- 100
- Issue
- 2
- Pages
- E223-E231
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2020471695
- Cited by
- 26
- References
- 8
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.